Showing results (491-500 of 528) with videos related to
Sort By:
Pageof 53
Thoracic Cancer|December 23, 2021
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapyGiuseppe L Banna, Marcello Tiseo, Diego L Cortinovis, et al.Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME databaseGiovanni Leuzzi, Federica Sabia, Claudia Proto, et al.Lung Cancer (Amsterdam, Netherlands)|February 20, 2021
A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysisLorenzo Spaggiari, Luca Bertolaccini, Francesco Facciolo, et al.La Radiologia Medica|July 7, 2026
Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM)Vincenza Granata, Alessandro Serafini, Roberta Fusco, et al.Scientific Reports|December 8, 2015
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancerNiki Karachaliou, Jordi Codony-Servat, Cristina Teixidó, et al.Nature Communications|June 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world studyDavide Massa, Theodoros Foukakis, Sylvie Giacchetti, et al.Lung Cancer (Amsterdam, Netherlands)|September 30, 2025
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS databaseMaria Lucia Reale, Daniela Scattolin, Antonio Vitale, et al.European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.Cancers|January 11, 2024
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA StudyMarina Elena Cazzaniga, Paolo Pronzato, Domenico Amoroso, et al.European Journal of Cancer (Oxford, England : 1990)|December 31, 2025
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas databaseClaudio Sini, Alessandro Russo, Diego Cortinovis, et al.Pageof 53